
Abbvie Inc
NYSE:ABBV

Intrinsic Value
The intrinsic value of one
ABBV
stock under the Base Case scenario is
160.14
USD.
Compared to the current market price of 188.09 USD,
Abbvie Inc
is
Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Abbvie Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Abbvie Inc
Balance Sheet Decomposition
Abbvie Inc
Current Assets | 25.6B |
Cash & Short-Term Investments | 5.6B |
Receivables | 10.9B |
Other Current Assets | 9.1B |
Non-Current Assets | 109.6B |
Long-Term Investments | 279m |
PP&E | 5.1B |
Intangibles | 95B |
Other Non-Current Assets | 9.1B |
Free Cash Flow Analysis
Abbvie Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Abbvie Inc
Revenue
|
56.3B
USD
|
Cost of Revenue
|
-16.9B
USD
|
Gross Profit
|
39.4B
USD
|
Operating Expenses
|
-22.9B
USD
|
Operating Income
|
16.5B
USD
|
Other Expenses
|
-12.3B
USD
|
Net Income
|
4.2B
USD
|
ABBV Profitability Score
Profitability Due Diligence
Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Score
Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
ABBV Solvency Score
Solvency Due Diligence
Abbvie Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Score
Abbvie Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for
ABBV
is 217.88 USD
with a low forecast of 174.73 USD and a high forecast of 263.55 USD.
Dividends
Current shareholder yield for ABBV is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ABBV
stock under the Base Case scenario is
160.14
USD.
Compared to the current market price of 188.09 USD,
Abbvie Inc
is
Overvalued by 15%.